Rhumbline Advisers Has $18.06 Million Stake in Cytokinetics, Incorporated (NASDAQ:CYTK)
Rhumbline Advisers lifted its stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 1.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 383,883 shares of the biopharmaceutical company’s stock after purchasing an additional 5,207 shares during the period. Rhumbline […]
Rhumbline Advisers lifted its stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 1.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 383,883 shares of the biopharmaceutical company’s stock after purchasing an additional 5,207 shares during the period. Rhumbline […]
